X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Strides Arcolab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs STRIDES SHASUN LTD - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA STRIDES SHASUN LTD ABBOTT INDIA/
STRIDES SHASUN LTD
 
P/E (TTM) x 44.5 13.4 330.8% View Chart
P/BV x 11.1 1.6 713.0% View Chart
Dividend Yield % 0.6 0.6 95.1%  

Financials

 ABBOTT INDIA   STRIDES SHASUN LTD
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
STRIDES SHASUN LTD
Mar-17
ABBOTT INDIA/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs6,0151,275 471.9%   
Low Rs3,707918 403.8%   
Sales per share (Unadj.) Rs1,236.9389.6 317.5%  
Earnings per share (Unadj.) Rs122.228.0 436.9%  
Cash flow per share (Unadj.) Rs129.048.9 263.8%  
Dividends per share (Unadj.) Rs35.004.50 777.8%  
Dividend yield (eoy) %0.70.4 175.4%  
Book value per share (Unadj.) Rs521.2303.1 172.0%  
Shares outstanding (eoy) m21.2589.42 23.8%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.92.8 139.6%   
Avg P/E ratio x39.839.2 101.5%  
P/CF ratio (eoy) x37.722.4 168.1%  
Price / Book Value ratio x9.33.6 257.8%  
Dividend payout %28.616.1 178.0%   
Avg Mkt Cap Rs m103,29698,036 105.4%   
No. of employees `0003.05.8 51.0%   
Total wages/salary Rs m3,3705,881 57.3%   
Avg. sales/employee Rs Th8,891.86,005.9 148.1%   
Avg. wages/employee Rs Th1,140.01,014.0 112.4%   
Avg. net profit/employee Rs Th878.3431.2 203.7%   
INCOME DATA
Net Sales Rs m26,28434,834 75.5%  
Other income Rs m5041,686 29.9%   
Total revenues Rs m26,78936,520 73.4%   
Gross profit Rs m3,6656,428 57.0%  
Depreciation Rs m1441,872 7.7%   
Interest Rs m82,269 0.4%   
Profit before tax Rs m4,0173,973 101.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m04 0.0%   
Extraordinary Inc (Exp) Rs m0-1,006 0.0%   
Tax Rs m1,421470 302.3%   
Profit after tax Rs m2,5962,501 103.8%  
Gross profit margin %13.918.5 75.6%  
Effective tax rate %35.411.8 299.0%   
Net profit margin %9.97.2 137.6%  
BALANCE SHEET DATA
Current assets Rs m14,44638,165 37.9%   
Current liabilities Rs m4,72530,402 15.5%   
Net working cap to sales %37.022.3 166.0%  
Current ratio x3.11.3 243.6%  
Inventory Days Days5177 66.5%  
Debtors Days Days20104 18.7%  
Net fixed assets Rs m1,11337,639 3.0%   
Share capital Rs m213894 23.8%   
"Free" reserves Rs m10,80826,210 41.2%   
Net worth Rs m11,07627,105 40.9%   
Long term debt Rs m016,377 0.0%   
Total assets Rs m16,24181,168 20.0%  
Interest coverage x497.02.8 18,066.4%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.60.4 377.1%   
Return on assets %16.05.9 272.9%  
Return on equity %23.49.2 254.0%  
Return on capital %36.312.1 301.6%  
Exports to sales %0.60-   
Imports to sales %12.60-   
Exports (fob) Rs m162NA-   
Imports (cif) Rs m3,322NA-   
Fx inflow Rs m26813,465 2.0%   
Fx outflow Rs m3,9274,076 96.4%   
Net fx Rs m-3,6599,389 -39.0%   
CASH FLOW
From Operations Rs m2,5142,881 87.3%  
From Investments Rs m-800-7,051 11.3%  
From Financial Activity Rs m-8033,382 -23.7%  
Net Cashflow Rs m912-788 -115.8%  

Share Holding

Indian Promoters % 0.0 27.7 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 37.8 20.9%  
FIIs % 0.1 8.6 1.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 25.9 66.0%  
Shareholders   18,270 56,241 32.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   CIPLA  PFIZER  ALKEM LABORATORIES  SHASUN PHARMA  SANOFI INDIA  

Compare ABBOTT INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Firm US Markets; Sun Pharma, Software Stocks & Other Top Cues to Sway the Markets Today(Pre-Open)

Indian share markets finished the previous trading session on a strong note amid firm Asian markets after comments from a Federal Reserve official eased worries about faster rate hikes in US.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Blueprint for Sensex 100,000(The 5 Minute Wrapup)

Feb 20, 2018

Investing in stocks is not about index gazing. There are 3-Ms that could help pick the right stocks.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

A New Quest for the Stock Market's MOST Profitable Ideas...(Smart Contrarian)

Feb 23, 2018

If you want to receive the best ideas in the Indian stick markets...you need to heed this important announcement.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Feb 26, 2018 09:33 AM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS